458 related articles for article (PubMed ID: 28699986)
21. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
Young WF
Endocrinology; 2003 Jun; 144(6):2208-13. PubMed ID: 12746276
[TBL] [Abstract][Full Text] [Related]
22. [The difficulties in differential diagnosis of primary aldosteronism subtypes in women with strokes at a young age].
Bohdanowicz-Pawlak A; Szymczak J; Jakubowska J; Brona A
Endokrynol Pol; 2009; 60(6):492-6. PubMed ID: 20041369
[TBL] [Abstract][Full Text] [Related]
23. Treatment of primary hyperaldosteronism.
Araujo-Castro M
Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
[TBL] [Abstract][Full Text] [Related]
24. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
25. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
[TBL] [Abstract][Full Text] [Related]
26. Primary aldosteronism: management issues.
Young WF
Ann N Y Acad Sci; 2002 Sep; 970():61-76. PubMed ID: 12381542
[TBL] [Abstract][Full Text] [Related]
27. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.
Ohno Y; Sone M; Inagaki N; Kawashima A; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Ichijo T; Katabami T; Wada N; Sakamoto R; Ogawa Y; Yoshimoto T; Yamada T; Kawashima J; Matsuda Y; Kobayashi H; Kamemura K; Yamamoto K; Otsuki M; Okamura S; Izawa S; Okamoto R; Tamura K; Tanabe A; Naruse M;
Hypertension; 2020 Jun; 75(6):1475-1482. PubMed ID: 32248705
[TBL] [Abstract][Full Text] [Related]
28. Primary aldosteronism: diagnostic and therapeutic considerations.
Nishizaka MK; Calhoun DA
Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
[TBL] [Abstract][Full Text] [Related]
29. Primary aldosteronism: emerging trends.
Galati SJ; Hopkins SM; Cheesman KC; Zhuk RA; Levine AC
Trends Endocrinol Metab; 2013 Sep; 24(9):421-30. PubMed ID: 23796656
[TBL] [Abstract][Full Text] [Related]
30. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Amar L; Plouin PF; Steichen O
Orphanet J Rare Dis; 2010 May; 5():9. PubMed ID: 20482833
[TBL] [Abstract][Full Text] [Related]
32. Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?
Okamoto K; Ohno Y; Sone M; Inagaki N; Ichijo T; Yoneda T; Tsuiki M; Wada N; Oki K; Tamura K; Kobayashi H; Izawa S; Tanabe A; Naruse M
Front Endocrinol (Lausanne); 2021; 12():645395. PubMed ID: 33912136
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and therapy of primary aldosteronism: new aspects].
Asbach E; Reincke M
Dtsch Med Wochenschr; 2022 Jan; 147(3):92-97. PubMed ID: 35100641
[TBL] [Abstract][Full Text] [Related]
34. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
35. Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report.
Miyamoto S; Yoshida Y; Ozeki Y; Okamoto M; Gotoh K; Masaki T; Nishida H; Fujinami H; Shin T; Daa T; Asayama Y; Shibata H
BMC Endocr Disord; 2023 Feb; 23(1):44. PubMed ID: 36797699
[TBL] [Abstract][Full Text] [Related]
36. Primary aldosteronism: part II: subtype differentiation and treatment.
Rossi GP; Seccia TM; Pessina AC
J Nephrol; 2008; 21(4):455-62. PubMed ID: 18651533
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of primary aldosteronism: an updated review.
Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
[TBL] [Abstract][Full Text] [Related]
38. Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication.
Hoshi S; Onagi A; Tanji R; Honda-Takinami R; Matsuoka K; Hata J; Sato Y; Akaihata H; Kataoka M; Ogawa S; Kojima Y
BMC Endocr Disord; 2023 Nov; 23(1):243. PubMed ID: 37932696
[TBL] [Abstract][Full Text] [Related]
39. Primary aldosteronism: challenges in diagnosis and management.
Galati SJ
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):355-69. PubMed ID: 26038205
[TBL] [Abstract][Full Text] [Related]
40. Prediction of successful outcome in patients with primary aldosteronism.
Moo TA; Zarnegar R; Duh QY
Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
